Translational dysfunction based therapeutics

Details Translational dysfunction based therapeutics Translational dysfunction based therapeutics

A - Human Necessities

61

K

A61K 31/7056 (2006.01) A61K 31/4025 (2006.01) A61K 31/4155 (2006.01) A61P 35/00 (2006.01) C07H 19/056 (2006.01) C07H 19/167 (2006.01) C07H 19/20 (2006.01) C12N 5/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2633715

Provided are methods and compositions for inhibiting eukaryotic translation initiation factor eEF4E. Such methods and compositions may be used alone or in conjunction with other therapies, such as gene therapies, for inhibiting cell proliferation and/or treating cancer.

Cette invention concerne des méthodes et des compositions visant à inhiber le facteur d'initiation de la traduction eucaryote eEF4E. Ces méthodes et compositions peuvent être utilisées seules ou conjointement à d'autres thérapies, telles que des thérapies géniques, pour inhiber la prolifération cellulaire et/ou traiter le cancer.

Affiliated with

Also associated with

Rating

Translational dysfunction based therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Translational dysfunction based therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Translational dysfunction based therapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1995785